Targeting cancer cells with mutated KRAS with krasin, a novel synthetic cycloheptapeptide

被引：0
|
作者：
Sheikhnejad, R. [1 ]
Tahoori, F. [1 ]
Shokri, B. [1 ]
机构：
[1] Oshida Novel Pharmatech, Incubat Ctr Pharmaceut Technol, Tehran, Iran
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 61卷
关键词：
D O I：
10.1016/S0959-8049(16)61733-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
895
引用
收藏
页码：S208 / S208
页数：1
相关论文
共 50 条
  • [1] Targeting KRAS-Mutated NSCLC: Novel TKIs and Beyond
    Cantor, David J.
    Aggarwal, Charu
    CLINICAL CANCER RESEARCH, 2023, 29 (18) : 3563 - 3565
  • [2] Determination of synthetic lethal interactions in KRAS oncogene dependent cancer cells reveals novel therapeutic targeting strategies
    Molina-Arcas, Miriam
    Hancock, David
    Steckel, Michael
    Downward, Julian
    CANCER RESEARCH, 2012, 72
  • [3] Determination of Synthetic Lethal Interactions in KRAS Oncogene Dependent Cancer Cells Reveals Novel Therapeutic Targeting Strategies
    Arcas, M. Molina
    Hancock, D.
    Steckel, M.
    Downward, J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S90 - S91
  • [4] Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies
    Michael Steckel
    Miriam Molina-Arcas
    Britta Weigelt
    Michaela Marani
    Patricia H Warne
    Hanna Kuznetsov
    Gavin Kelly
    Becky Saunders
    Michael Howell
    Julian Downward
    David C Hancock
    Cell Research, 2012, 22 : 1227 - 1245
  • [5] Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies
    Steckel, Michael
    Molina-Arcas, Miriam
    Weigelt, Britta
    Marani, Michaela
    Warne, Patricia H.
    Kuznetsov, Hanna
    Kelly, Gavin
    Saunders, Becky
    Howell, Michael
    Downward, Julian
    Hancock, David C.
    CELL RESEARCH, 2012, 22 (08) : 1227 - 1245
  • [6] Targeting ARID1A-mutated gastric cancer cells with synthetic lethal approaches
    Fang, Menghan
    Lin, Youfen
    Xue, Chaorong
    Sheng, Kaiqin
    Guo, Zegeng
    Han, Yuting
    Lin, Hanbin
    Wu, Yuecheng
    Howell, Stephen B.
    Lin, Xu
    Lin, Xinjian
    CANCER RESEARCH, 2024, 84 (06)
  • [7] Novel therapeutic strategy for Kras mutated colorectal cancer and PDAC
    Obi, Natsuno
    Takeda, Mizuho
    Masuda, Tatsuya
    Yanagida, Yohei
    Kobayakawa, Atsushi
    Sakuramoto, Naoya
    Hada, Asuka
    Horiuchi, Ayaka
    Sasaki, Asami
    Takeda, Kanako
    Matsuo, Hidemasa
    Adachi, Souichi
    Kamikubo, Yasuhiko
    CANCER SCIENCE, 2021, 112 : 434 - 434
  • [8] Selective targeting of KRAS mutant cancer cells by a novel small molecule compound
    Iskandar, Kartini
    Rezlan, Majidah
    Yadav, Sanjiv K.
    Pervaiz, Shazib
    CANCER RESEARCH, 2014, 74 (19)
  • [9] Targeting mutated GTPase KRAS in tumor therapies
    Fan, Guangjin
    Lou, Linlin
    Song, Zhendong
    Zhang, Xiaolei
    Xiong, Xiao-Feng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 226
  • [10] Novel modalities in the treatment of patients with KRAS-mutated colorectal cancer
    Dimou, Anastasios
    Syrigos, Konstantinos
    Saif, Muhammad Wasif
    ANTI-CANCER DRUGS, 2011, 22 (05) : 384 - 391
12345